Exposure-response (E-R) relationship of ramucirumab (RAM) from two global, randomized, double-blind, phase 3 studies of patients (Pts) with advanced second-line gastric cancer. A phase I/II study of ...
From the Evans Memorial, Massachusetts Memorial Hospitals, and the Department of Medicine, Boston University School of Medicine. Select the format you want to export the citation of this publication.
Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib The ideas and opinions expressed in these Data Supplements do not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results